pfizer glp-1 drug 2 Companies Poised to Capitalize on the Rise of Weight Loss Drugs Pfizer Pill Obesity Treatment: Danuglipron
Description
Additionally, several key clinical trial readouts delivered compelling data across multiple indications, for example (see Figure 1): Semaglutide: STEP-HFpEF (functional benefits in HFpEF), STEP-9 (pain reduction in knee osteoarthritis), STEP-10 (reversion to normoglycaemia in pre-diabetic, obese patients), ESSENCE (resolution of MASH, improvement in fibrosis) Tirzepatide: SUMMIT (risk reduction in HFpEF outcomes
There is no argument that the drugs are much more potent and faster acting than your bodies natural GLP-1 hormones
The first clinical study of an oral small-molecule GLP-1 receptor agonist suggests effective glycemic control and weight loss in patients with type 2 diabetes.
Berberine has been studied
Evaluate the benefits and concerns surrounding GLP-1 treatments
